Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Finasteride increases CD8+ T cells in BPH tissues.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Estrogen may help improve COVID-19 outcomes, especially in women.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Stopping finasteride improves sperm quality but not semen volume in young men.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Hirsutism, excessive male-pattern hair in women, can be caused by high androgens or skin sensitivity, diagnosed by testosterone levels, and treated with hair removal and hormone therapy.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Antiandrogens don't help with COVID-19 and aren't recommended.

Gut bacteria overgrowth may cause some Post-Finasteride Syndrome symptoms.

Gut bacteria overgrowth may cause some Post-Finasteride Syndrome symptoms.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.